Golden eardrops

Golden Eardrops (Ehrendorferia chrysantha / Dicentra chrysantha): A Comprehensive Reference

1. Identity, Taxonomy, and Botanical Description

1.1 Names and Taxonomic Position

The plant known as golden eardrops bears the accepted scientific name Ehrendorferia chrysantha, with Dicentra chrysantha treated as a well-established synonym; it is a biennial to perennial plant placed in the family Papaveraceae. An older synonymous name, Dielytra chrysantha Hooker & Arnott, also appears in herbarium literature. The genus name Dicentra reflects its historical placement: the name is derived from the Greek dis, meaning "twice," and centron, meaning "spur" — a reference to the distinctive twice-spurred shape of its flowers. The epithet chrysantha is Greek for "golden-flowered," directly describing the plant's most conspicuous feature. The species is additionally listed under the common name "ear drops" in some California horticultural references.

Taxonomically, Ehrendorferia chrysantha (syn. Dicentra chrysantha) is classified within the Fumariaceae, a family of showy wildflowers that is sometimes included in the broader Papaveraceae, the poppy family. About 35 isoquinoline alkaloids have been isolated from the Fumariaceae, and such compounds are present in the tissues of all species.

The currently accepted binomial, Dicentra chrysantha (Hooker & Arnott) Walpers, was formally published in Repert. Bot. Syst. 1: 118 in 1842, based on the basionym Dielytra chrysantha Hooker & Arnott, which appeared in Bot. Beechey Voy. 320, plate 73, in 1838.

1.2 Morphology and Physical Description

Golden eardrops is a somewhat bushy, taprooted perennial herb that may reach 1.5 meters in height. It has many tall, smooth stems with long, waxy, pale leaves that are divided into many lobes and leaflets. Atop each branch of each stem is a panicle of bright yellow aromatic flowers; each flower has curving, pointed outer petals sculpted outward from the center, which is covered by a ridge made up of the inner petals.

The plant has a taproot, and its leaves are blue-green with many lobed leaflets. Flowers are yellow and aromatic, with the tips of two outer petals curved outward from two central petals, borne in panicles at the top of branched stems up to 1.5 m tall. Seeds are borne in a capsule 1–2 cm long, and they usually do not germinate unless exposed to fire.

The flowers are erect with a slightly pungent odor; pedicels are rigid at 2–10 mm; the sepals are ovate to cordate or nearly round; and the petals are golden yellow, with outer petals 10–22 mm long. Capsules are ovoid, attenuate at both ends, 5–32 mm long and 5–8 mm wide.

1.3 Native Habitat and Geographic Range

Golden eardrops is native to dry, brushy areas prone to wildfire in diverse regions of California, and in Baja California. Its habitat includes disturbed areas, slopes, yellow pine forest, foothill woodland, and chaparral. In the drier southern portion of its range, golden eardrops grows on north-facing slopes on well-drained shale; in the north, it grows in south-facing pockets at elevations up to 5,000 feet.

1.4 Fire Ecology and Germination

Golden eardrops is among the classic "fire follower" plants of the California chaparral. Many chaparral plant species appear only after a fire, when the dense shrubs have been burned away. Golden eardrops (Ehrendorferia chrysantha) has seeds that need fire to germinate, and can bloom in great numbers after fires, taking advantage of abundant soil nutrients and increased light at ground level.

In Dicentra chrysantha, neither heat alone, smoke alone, nor any of the other common germination-inducing treatments is sufficient; germination is triggered only by a combination of soil burial followed by smoke treatment. Following California chaparral fires, golden eardrops may show up in large numbers, as documented after major fires on Mount Diablo in 1931 and 1977.

2. Traditional and Historical Use

2.1 Relationship to the Broader Dicentra Genus in Traditional Medicine

No published ethnobotanical record verified through peer-reviewed sources specifically documents Dicentra chrysantha (golden eardrops) being used medicinally by a named Native American group in California. The available ethnobotanical record instead documents medicinal use of closely related Dicentra species growing in adjacent and overlapping territories — particularly D. formosa (Pacific bleeding heart) and D. canadensis (turkey corn) — with the understanding that all members of the genus share the same characteristic alkaloid chemistry and were historically approached as medicinally interchangeable in some traditions.

Dicentra formosa (western or Pacific bleeding heart) and Dicentra canadensis (turkey corn) were once well-known herbal remedies but have fallen into obscurity. Their potential as anticancer remedies, as well as topical and internal analgesics and sedatives, suggest that they are worth reviewing. Dicentra belongs to the Fumariaceae family and is closely related to the Papaveraceae family, making it a cousin to such notables as the opium poppy and the gallbladder remedy Fumaria officinalis (fumitory).

2.2 Indigenous Peoples of Western North America

According to ethnobotanist Daniel Moerman (1998), Pacific bleeding heart (D. formosa) was used as an anthelmintic (vermifuge), a topical analgesic for toothache, and to promote hair growth by the Native American Skagit people of Washington State. It was also used by the Thompson River Indians of southern British Columbia, though the exact nature of their use was not recorded in available sources.

A decoction from the rhizome of D. formosa was used in the Pacific Northwest to expel intestinal worms, as recorded by Moerman (1986).

2.3 Eclectic Medical Tradition (19th–Early 20th Century, North America)

The American Eclectic physicians of the 19th century made extensive use of Dicentra species, including related preparations. Eclectic physicians including Finley Ellingwood MD, William Cook MD, and Harvey Wickes Felter MD extolled the tonic properties of Dicentra, finding it beneficial in treating syphilitic conditions, blood dyscrasias, and "glandular derangements." The plant was also used effectively for amenorrhea, dysmenorrhea, and chronic skin disorders. Fluid extracts, compound syrups, and tinctures were made from the deep yellow, pea-like tubers of the plant (Felter, 1898), described as "stimulating and moderately relaxing, acting slowly but persistently, and influencing the secretory organs, especially the kidneys and skin" (Cook, 1869).

2.4 Traditional Asian Use of Related Species

Dicentra spectabilis (bleeding heart), a closely related Asian species, is used in traditional Asian herbal medicine for removing blood stasis, expelling pathogenic wind, and subduing carbuncles. Dicentra spectabilis has been cultivated for centuries in temperate China and Japan, where it is now so widespread that the limits of its natural distribution are obscure; it was introduced into Europe only in the middle of the 19th century.

3. Chemical Constituents and Active Compounds

3.1 Alkaloid Profile of the Genus

About 35 isoquinoline alkaloids have been isolated from Fumariaceae, and such compounds are present in the tissues of all species; some of these alkaloids have been used medicinally, mostly in the past. A classic study specifically examined the alkaloids of Dicentra chrysantha itself: a reference cited in multiple chemical databases is titled "The Alkaloids of Fumariaceous Plants: XV. Dicentra chrysantha Walp. and Dicentra ochroleuca Engelm.", documenting the specific alkaloid profile of the golden eardrops plant. Across the genus, Dicentra contains several isoquinoline alkaloids of interest, including protopine, corydine, isocorydine, bulbocapnine, and dicentrine; several of these have shown cytotoxic and chemoprotective activities.

In the related species Dicentra spectabilis, methanolic extraction has yielded alkaloids including dihydrosanguinarine, sanguinarine, scoulerine, cheilanthifoline, corydine, and protopine. In the related Dicentra peregrina, the alkaloids isolated include isocorydine, corydine, dicentrine, protopine, dihydrosanguinarine, sanguinarine, cheilanthifoline, bicuculline, lederine, scoulerine, isoboldine, predicentrine, reticuline, and allocryptopine.

3.2 Major Compound Classes

The principal bioactive constituents identified across the Dicentra/Ehrendorferia genus fall into several structural subgroups of isoquinoline alkaloids:

• Aporphine alkaloids: Bulbocapnine and dicentrine are the most studied. Aporphine alkaloids have a tendency to bind to dopaminergic receptors; aporphines with an alpha C6a hydrogen (such as bulbocapnine) act as dopamine receptor antagonists at D1/D2 subtypes, while those with a beta C6a hydrogen produce agonists.
• Protoberberine alkaloids: Including protopine and coreximine. Protoberberines have been reported in Dicentra species and may have potential pharmacological properties in cancer treatment, as antidepressants, and in skin care.
• Benzophenanthridine alkaloids: Including sanguinarine and dihydrosanguinarine, shared with the closely related poppy family.
• Phthalide alkaloids: Including bicuculline, a well-characterized GABA-A receptor antagonist found in multiple Dicentra species.

3.3 Bulbocapnine: Mechanism of Action

Bulbocapnine is the most pharmacologically characterized alkaloid found in Dicentra species. Bulbocapnine is found in Corydalis (notably the European species C. cava) and Dicentra, genera of the plant family Fumariaceae; it has been shown to act as an acetylcholinesterase inhibitor and inhibits biosynthesis of dopamine via inhibition of the enzyme tyrosine hydroxylase.

More precisely, bulbocapnine acts as an acetylcholinesterase inhibitor — increasing neuromuscular transmission and spasm — and as a tyrosine hydroxylase inhibitor that blocks the effects of dopamine on peripheral dopamine receptors. Taken together, these properties can directly cause transient syndromes of frenzy, convulsions, tremor, opisthotonos spasms, hypertension, salivation, and vomiting, as well as a range of neurodegenerative effects.

Bulbocapnine is a fairly active tyrosine hydroxylase inhibitor that blocks the formation of dopamine, at least in vitro, and also inhibits dopamine-1 receptors in vitro.

3.4 Dicentrine: Mechanism of Action

Dicentrine intercalates DNA and induces DNA strand breaks through inhibition of DNA topoisomerases, which can result in cell cycle arrest from dicentrine-induced DNA lesions. Both bulbocapnine and dicentrine inhibit topoisomerase II in vitro, an action associated with inhibiting cancer cells (Woo et al., 1999).

3.5 Protopine

Protopine is a protoberberine-type alkaloid found throughout the genus. Research suggests a relatively weak effect of protopine on platelet aggregation compared to bulbocapnine. Protopine has a broad pharmacological profile across the Papaveraceae/Fumariaceae family and is shared with species such as California poppy (Eschscholtzia californica) and opium poppy (Papaver somniferum).

3.6 Amyloid-Related Activity of Bulbocapnine

Like apomorphine, bulbocapnine is reported to be an inhibitor of amyloid beta protein (Aβ) fiber formation, whose presence is a hallmark of Alzheimer's disease. Bulbocapnine is thus a potential therapeutic candidate under the amyloid hypothesis of Alzheimer's disease.

4. Scientific Evidence by Area of Use

Important caveat: The scientific literature on Dicentra chrysantha specifically as a medicinal botanical is extremely sparse. Most pharmacological research has been conducted on isolated alkaloids (bulbocapnine, dicentrine, protopine) derived from related Dicentra and Corydalis species, or on whole-plant extracts of D. spectabilis, D. formosa, or D. canadensis. No randomized controlled clinical trials in humans have been identified for golden eardrops (E. chrysantha) as a discrete medicinal entity. All evidence reviewed below is therefore either in vitro, animal-based, or derived from pharmacological studies of constituent compounds — not from clinical studies of D. chrysantha preparations per se. Evidence strength for all areas is characterized as preliminary.

4.1 Neurological / Dopaminergic System

In animal studies (mice and rats), the central effects of bulbocapnine have been studied, with the compound producing catalepsy. Three types of drugs were found to attenuate bulbocapnine-induced catalepsy: antihistaminics (diphenhydramine, promethazine), antiparkinsonians (amantadine, trihexyphenidyl), and antidepressants (imipramine). This profile of antagonism indicates that bulbocapnine's cataleptic effect is partly mediated through dopaminergic pathways.

Bulbocapnine has been found to be an effective, apparently competitive inhibitor of dopamine-mediated depressor responses in the anesthetized cat model. The duration of action as a dopaminergic antagonist exceeded 3 hours after an intravenous dose of 8 mg/kg. In the same preparation, bulbocapnine did not inhibit the responses to acetylcholine, histamine, or isoproterenol, indicating a selectivity of action.

Bulbocapnine has reportedly been used "in the treatment of Ménière's disease, for muscular tremors, and as a pre-anesthetic" (Stern, 2008), though these historical clinical uses are not supported by modern controlled trials.

Evidence strength: Preclinical (animal and in vitro) only. No controlled human trials for D. chrysantha or bulbocapnine in neurological indications have been identified.

4.2 Anticancer / Cytotoxic Activity

Simple aporphinoids such as boldine and dicentrine, as well as oxo-, pro-, and dehydro-aporphines, have been reviewed for cytotoxic activity. Their mechanisms of action are not fully understood, but DNA-manipulating enzymes such as polymerases and topoisomerases are among the most frequently cited targets for these benzylisoquinoline compounds. This body of research presents an updated view of the cytotoxic properties of aporphinoids and their potential contribution to the development of anticancer agents.

Other compounds from Dicentra related to cardiac glycosides induced apoptosis in human tumor cell lines (McNulty et al., 2007). More research is warranted on Dicentra as a treatment for cancer.

Toxicity studies have suggested that most aporphine alkaloids had non-toxic or low-toxicity properties; however, long-term and high-dose safety tests in clinical practice are still lacking.

Evidence strength: In vitro and preclinical only. No clinical trials in humans have been identified for D. chrysantha or its constituent alkaloids in oncology.

4.3 Cardiovascular / Antiplatelet Activity

Among tested isoquinoline compounds, bulbocapnine appeared to be a candidate for an antiplatelet compound in whole human blood models. Unlike the related alkaloid dicentrine, it does not bind to topoisomerases, so cytostatic effects are not expected; it also possesses cardiovascular effects such as peripheral vasodilation. Bulbocapnine is therefore potentially useful as a cardiovascular drug candidate, but might cause bleeding, as is the case with all other clinically or experimentally confirmed antiplatelet compounds.

Its potency was lower than clinically used aspirin (ASA), but it had a different mechanism of action: ASA inhibits cyclooxygenase 1, but bulbocapnine had no effect on this enzyme, and its effects were partly mediated by antagonism at thromboxane receptors.

Evidence strength: In vitro / preclinical. No clinical trials in humans have been identified.

4.4 Anthelmintic / Vermifuge Activity

A decoction from the rhizome of D. formosa has been used in the Pacific Northwest to expel intestinal worms, as documented ethnobotanically by Moerman (1986). This use is supported only by ethnobotanical documentation; no clinical or pharmacological verification has been identified for D. chrysantha.

Evidence strength: Traditional/ethnobotanical record only; no controlled pharmacological or clinical evidence.

4.5 Analgesic and Sedative Activity

Several Dicentra species were used as analgesics and mild sedatives in traditional medicine. Fluid extracts and tinctures were described by Eclectic physicians as "stimulating and moderately relaxing, acting slowly but persistently, and influencing the secretory organs, especially the kidneys and skin" (Cook, 1869). Bulbocapnine acts as an acetylcholinesterase and tyrosine hydroxylase inhibitor in mammals including humans, inducing catalepsy and inhibition of reflexes and motor activities of striated muscles.

Evidence strength: Traditional documentation and animal pharmacology only; no controlled human trials.

5. Body Systems and Health Areas Associated with Golden Eardrops

Based on verified traditional uses and the established pharmacology of its constituent alkaloids, the following body systems and health areas are associated with golden eardrops and related Dicentra species:

• Central nervous system: Dopaminergic modulation via bulbocapnine (dopamine receptor antagonism, tyrosine hydroxylase inhibition); historically associated with catalepsy, tremors, and Ménière's disease.
• Neurodegenerative disease research: Bulbocapnine's inhibition of amyloid beta protein fiber formation has drawn preliminary research interest in Alzheimer's disease.
• Oncology (preclinical): Dicentrine, bulbocapnine, and related aporphinoids have shown in vitro cytotoxic and topoisomerase-inhibiting effects.
• Cardiovascular system: Bulbocapnine has demonstrated antiplatelet and vasodilatory effects in laboratory models.
• Gastrointestinal / anthelmintic: Traditional use for expelling intestinal parasites in related species.
• Reproductive system / gynecological: Historical Eclectic use for amenorrhea and dysmenorrhea.
• Dermatological: Historical Eclectic use for chronic skin disorders; external use as a poultice noted in related species.
• Renal and lymphatic systems: Eclectic physicians described influence on kidney secretory function.

6. Dosage Forms and Reported Dosages

There are no standardized dosage regimens established by regulatory bodies or systematic clinical trials for golden eardrops (E. chrysantha / D. chrysantha) as a dietary supplement. The following preparations are documented historically or in the literature on related species:

• Fluid extract and tincture: Fluid extracts, compound syrups, and tinctures were made from the deep yellow, pea-like tubers of related Dicentra species by Eclectic physicians (Felter, 1898). Specific dose quantities for D. chrysantha are not recorded in the available literature.
• Decoction (root/rhizome): A decoction from the rhizome was documented for anthelmintic use in the Pacific Northwest.
• Bulbocapnine (isolated alkaloid, pre-anesthetic use, animal toxicology only): The toxicity of bulbocapnine and its safety as a pre-anesthetic agent have been determined in white mice, with an LD50 of 195 mg/kg, a minimum lethal dose of 140 mg/kg, and an optimum dose for suppression of muscular struggling of 15 mg/kg, giving a margin of safety of 9.4:1. These figures are from animal pharmacology and have no direct application to human dosing.

No standardized commercial supplement dosage has been identified for E. chrysantha / D. chrysantha specifically. It is not currently listed in the FDA's dietary supplement database, nor does it appear in WHO monographs, the European Pharmacopoeia, or the German Commission E monographs as a stand-alone supplement ingredient.

7. Safety Considerations and Toxicology

7.1 Whole-Plant Toxicity

All parts of Dicentra plants may cause stomach upset if ingested by humans; they are also toxic to animals (cattle, sheep, and dogs), as they contain isoquinoline alkaloids. The foliage may aggravate skin allergies.

Bleeding heart plants contain isoquinoline alkaloids, making them poisonous to humans and animals, with all parts of the plant toxic when ingested.

7.2 Veterinary Toxicity

Cattle find D. cucullaria and D. canadensis distasteful and usually do not ingest the plants unless suitable forage is unavailable; when they do, the toxic alkaloid cucullarine can bring about local anaesthesia, narcosis, convulsions, and death.

Bulbocapnine, a primary alkaloid of Dicentra, is described as deadly for cattle but psychoactive for humans, and has also been investigated in modern medicine as an alkaloid useful in treating a range of muscular-related conditions. For thousands of years, farmers have learned to keep sheep and cattle away from 'bleeding heart' or 'Dutchman's breeches' poppies, because direct ingestion can kill the animals, due to the bulbocapnine they contain.

7.3 Neurological and Autonomic Toxicological Profile

Bulbocapnine acts as an acetylcholinesterase inhibitor, increasing neuromuscular transmission and spasm, and as a tyrosine hydroxylase inhibitor that blocks the effects of dopamine on peripheral dopamine receptors. Up to very high doses, bulbocapnine has little influence on heart action and blood pressure; it stimulates respiration up to toxic doses, and respiratory failure occurs shortly before heart failure.

7.4 Antiplatelet and Bleeding Risk

Bulbocapnine is potentially useful as a cardiovascular drug candidate, but might cause bleeding, as is the case with all other clinically or experimentally confirmed antiplatelet compounds.

7.5 Skin Sensitization

The foliage of Dicentra species may aggravate skin allergies. Contact with the plant's sap has been associated with dermal irritation in sensitive individuals.

7.6 Absence of Clinical Safety Data

Toxicity studies have suggested that most aporphine alkaloids have non-toxic or low-toxicity properties in acute settings; however, long-term and high-dose safety tests in clinical practice are still lacking. No clinical pharmacokinetic or pharmacodynamic studies have been published for E. chrysantha preparations in humans. Given the known neuropharmacological activity of its constituent alkaloids — particularly dopaminergic antagonism by bulbocapnine — interactions with dopaminergic medications (including antipsychotics, anti-Parkinson drugs, and dopamine agonists) are plausible, though not documented in controlled studies specific to this plant.

8. Current Status and Research Outlook

Golden eardrops (Ehrendorferia chrysantha) remains botanically well-characterized as a California endemic fire-follower in the Papaveraceae/Fumariaceae family. Its chemical relationship to medically important alkaloid-producing plants (Corydalis, Fumaria, the opium poppy family) is well-established through phytochemical analysis of both the species itself and the broader genus. However, its status as a discrete dietary supplement or therapeutic botanical is negligible at the time of writing: it does not appear in major pharmacopeias, is not the subject of any registered clinical trials, and lacks the human safety and efficacy data that would be required for characterization as a medicinal product in any major jurisdiction.

The alkaloids it shares with related species — particularly bulbocapnine, dicentrine, and protopine — have attracted genuine scientific interest in areas including dopaminergic neuropharmacology, Alzheimer's disease research, antiplatelet drug development, and oncology. A review by Stevigny and colleagues (2005) examined the cytotoxic properties of the aporphinoids and their potential contribution to the development of anticancer agents. The authors concluded that more research is warranted on Dicentra as a treatment for cancer. All such research, however, remains at the preclinical stage.

References

• JSTOR Global Plants — Dicentra chrysantha (Hook. & Arn.) Walp. [family PAPAVERACEAE]: Flora of North America entry and herbarium records
• Wikipedia — Ehrendorferia chrysantha
• Calscape — Ehrendorferia chrysantha (Ear Drops): Plant profile and ecology
• U.S. Fish & Wildlife Service — Golden Eardrops (Dicentra chrysantha) Species Profile
• Flora of North America (FNA) — Dicentra genus treatment, Vol. 3
• Flora of North America (FNA) Beta — Dicentra: Ethnobotanical notes and alkaloid content
• Naturopathic Doctor News and Review (NDNR) — Dicentra spp: Remembering a Forgotten Medicine (peer-reviewed references cited throughout)
• MDPI Toxins — Can Isoquinoline Alkaloids Affect Platelet Aggregation in Whole Human Blood? (2022)
• ScienceDirect Topics — Bulbocapnine: Pharmacology and dopaminergic receptor activity
• Psychopharmacology (Springer) — Studies on the central effects of bulbocapnine
• Naunyn-Schmiedeberg's Archives of Pharmacology (Springer) — Effect of bulbocapnine as a peripheral dopamine receptor antagonist in the anesthetized cat
• Wikipedia — Bulbocapnine: Chemical and pharmacological profile
• ScienceDirect — The Use of Bulbocapnine in Pre-Anesthetic Medication: Toxicological data
• Springer — Alkaloids of Dicentra (extraction and isolation study)
• PMC / Journal of Advanced Research — Natural aporphine alkaloids: A comprehensive review of phytochemistry, pharmacokinetics, anticancer activities, and clinical application (2024)
• PubMed — Stévigny C et al. Cytotoxic and antitumor potentialities of aporphinoid alkaloids. Curr Med Chem Anticancer Agents. 2005;5(2):173–82.
• USGS — Smoke-induced seed germination in California chaparral (Keeley & Fotheringham, 1998)
• Sacramento Valley CNPS — Chaparral ecology and fire-follower species including Ehrendorferia chrysantha
• Bay Nature — Fire followers, including golden eardrops (Ehrendorferia chrysantha), Mount Diablo
• California Gardens — Dicentra chrysantha / Ehrendorferia chrysantha habitat notes
• Pharmaceutical Networking / Biosynth — Molecule of the Month: Bulbocapnine
• ResearchGate — Smoke-Induced Seed Germination in California Chaparral (Keeley & Fotheringham)